tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Naureen Quibria, 11 are a BUY (91.67%), 1 are a HOLD (8.33%).
Analyst Naureen Quibria works at CAPITAL ONE with a stock forecast success ratio of 16.67% fulfilled within 101.33 days on average.
Naureen Quibria’s has documented 22 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ONCT, Oncternal Therapeutics at 04-Apr-2023.
Analyst best performing recommendations are on ONCT (ONCTERNAL THERAPEUTICS).
The best stock recommendation documented was for ONCT (ONCTERNAL THERAPEUTICS) at 5/10/2022. The price target of $3.5 was fulfilled within 608 days with a profit of $2.5 (250%) receiving and performance score of 4.11.
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
7
$1.12 (19.05%)
1 months 17 days ago
0/4 (0%)
$4.09 (140.55%)
Buy
8 months 7 days ago
0/2 (0%)
$15.89 (174.42%)
Buy
5
$-0.88 (-14.97%)
6
1 years 6 months 22 days ago
1/3 (33.33%)
$3.45 (222.58%)
533
Buy
25
$23.61 (1698.56%)
2 years 7 months 9 days ago
0/1 (0%)
$18.01 (257.65%)
What Year was the first public recommendation made by Naureen Quibria?
